KNOWLEDGE BANK

Interviews

Why Do Pharma Construction Projects Need Cost Certainty | Linesight | ISPE Singapore 2026 | Pharma Focus Asia

Associate Director, Project Controls, Linesight
Stephanie Ledwidge is an experienced project controls and cost management professional with expertise across the life sciences and pharmaceutical sectors She currently serves as Associate Director Project Controls at Linesight in Singapore Her experience spans project controls cost engineering project coordination and project delivery with previous roles supporting organisations including CSL Behr...

Articles

Why tier-2 and tier-3 cities are not included for clinical research

India is rapidly emerging as a global hub for clinical research with many international pharmaceutical companies and research organisations choosing the country as a site for their clinical trials

Research Insights

Mathematical Modelling to Guide Drug Development for Malaria Elimination

Mathematical models of the dynamics of a drug within the host are now frequently used to guide drug development These generally focus on assessing the efficacy and duration of response to guide patient therapy Increasingly antimalarial drugs are used at the population level to clear infections provide chemoprevention and to reduce onward transmission of infection However there is less clarity on the extent

Case Studies

Pharma Connects On Social: Top 20 Pharmaceutical Companies On Social Media

Abstract Pharmaceutical companies have taken a long time to start using social media in the first place but the industry is still struggling to fully embrace the digital space There are now more than two billion active social media users almost a third of the worlds population Customers are talking about health on the internet and in recent years s

Techno Trends

Merus Discovered Novel Zenocutuzumab (Zeno) for the treatment of NRG1+ Pancreatic Cancer

Merus discovered zenocutuzumab Zeno a novel treatment specifically designed for patients with advanced unresectable or metastatic NRG fusion NRG pancreatic cancer

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Novel Claudin Targeted C-terminal Clostridium Perfringens Enterotoxin Conjugated Anticancer Nanotherapeutics

Sushil Y. Raut

Sushil Y. Raut Assistant Professor and Head of Research Promotion Cell, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune. He has over 12 years of teaching and research experience. He has more than 25 research and review publications. He filed 3 Indian patents and over 20 national as well as international presentations in his credits. He is recipient of international research mobility fellowship and other prestigious awards.

 

Tanaji D. Nandgude

Tanaji D. Nandgude, Associate Professor, Dr. D. Y. Patil institute of Pharmaceutical Sciences and Research, Pimpri, Pune. He has 15 years of experience in teaching and research in pharmacy. He has more than 50 research/review papers, more than 60 research paper presentations, 5 book publications and granted projects to his credit. He is recipient of “Young Researcher Award”.

 

2

Current Research on Plant miRNA and Its Application in Disease Prevention

Atiyabanu N Saiyed

Atiya Saiyed is a Ph D student at Iladevi Cataract and IOL Research Centre and registered at Manipal Academy of Higher Education, Manipal. She is Senior Research Fellow from Indian Council of Medical Research, New Delhi. Atiya does research in the fields of molecular biology, cell biology, and cancer biology.

 

Abhay R. Vasavada

Abhay R. Vasavada is a well-known ophthalmologist who founded Raghudeep Eye Clinic (REH) and Iladevi Cataract and IOL Research Centre (ICIRC) in Ahmedabad, India. In 2011, the American Society of Cataract and Refractive Surgeons (ASCRS) gave him the Binkhorst Medal Lecture, making him the first Indian and just the second Asian to get the honour. He has almost 140 publications to his credit.

 

Kaid Johar SR

Kaid Johar SR is an Associate Professor in Department of Zoology and Biomedical TechnologyGujarat University, who specialized in cell and molecular biology, ophthalmology, cancer, and toxicology. He has almost 50 publications in prestigious journals.

 

3

3D Printing Revolutionising Nanotechnology

Mansi Athalye

Mansi Athalye is Assistant Professor in Department of Pharmaceutics at L. M. College of Pharmacy, India with approx. 10 years of teaching and research experience. She has published 12 papers in international and national journals and has presented 22 papers in various conferences as author and co-author with 1 Indian Patent granted in 2018.

 

Sagar Popat

Sagar Popat is research student pursuing M. Pharmacy in Pharmaceutics at L. M. College of Pharmacy. He has worked on the topic ‘Cataract of goat eye lens by Invitro and Ex-vivo method’. He has published 1 research article and has won 1st prize in oral presentation at national level conference.

 

4

Viksit Bharat@ 2047 envisioned the Indian Pharma Industry

Md. Faiyazuddin

Professor Md. Faiyazuddin, a distinguished academician with extensive experience working across the government, public and private sectors, sought to leverage his sixteen-year background in pharmacy education, product development, research consultation, and social pharmacy outreach activities in academia and industry. He is a Senior Professor and former Dean, R&D, Al-Karim University, who is lecturing on health and drug delivery research and holds visiting positions at prestigious universities in India and abroad. He has successfully completed research grants from various R&D agencies, such as SERB-DST and foreign agencies (DSR-UoH, DST, UiTM, Malaysia, Sick’s Children Hospital, Canada) worth Rs. 1.12 Million INR. With more than 120 research, conference, and review manuscripts, dozens of books and chapters, 15 accolades and awards, and various IPR have contributed greatly to the pharm fraternity of India. In addition to his daily job, Dr. Faiyazuddin has a keen interest in connecting researchers worldwide for practicing safe drugs under the flagship of the International Pharmaceutical Forum (a community of more than 250 pharma stalwarts across the globe).

 

Yogesh Subhash Chaudhari

Yogesh Subhash Chaudhari, a passionate educator at Dr L H Hiranandani College of Pharmacy, has contributed significantly to this field through research and review of papers in prestigious journals. His insights on AI for Pharmacist Newsletters on Linkedin are as follows.

 

5

Meaningful Advances in Virtual Cells

Brita Belli

Brita Belli is an award-winning science and tech writer and Senior Manager of Communications at Recursion, a clinical-stage TechBio company. Her writing has been featured in the New York Times, National Geographic, MSN.com, and Alternet, and she has covered AI drug discovery and other health tech topics for Future Medicine AI, On Drug Delivery, European Biopharmaceutical Review, and OR Manager Magazine. She’s the author of The Autism Puzzle: Connecting the Dots Between Environmental Toxins and Rising Autism Rates (Seven Stories Press).

press releasesRead more...

Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals Inc a global commercialstage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases today announced the commercial launch of IMCIVREE setmelanotide in Japan to treat patients living with acquired hypothalamic obesity HO...

Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement

Scinai Immunotherapeutics Ltd a biopharmaceutical company operating a growing contract development and manufacturing organization CDMO alongside an immunologyfocused therapeutic development platform today announced that its wholly owned subsidiary Scinai Biopharma Services Ltd has entered into a def...

BIX 2026 Counts Down to Opening with Post-GLP-1 Session on the Next Obesity Treatment Market

With one month to go before the opening BIOPLUSINTERPHEX KOREA BIX has released its full conference schedule Conference At a Glance BIX Koreas largest biotechnology and pharmaceutical convention will be held at COEX in Seoul from October to The event will bring together more than companies fr...

Foresee Pharmaceuticals Announces China NMPA Approval of CAMCEVI® 42 mg for the Treatment of Advanced Prostate Cancer; Changchun GeneScience Pharmaceutical will Commercialize in China

Foresee Pharmaceuticals announced that it was notified by its licensing partner Changchun GeneScience Pharmaceutical Co Ltd GenSci that Chinas National Medical Products Administration NMPA has approved the Marketing Authorization Application MAA for CAMCEVI mg a readytouse month subcutaneous depot...

Expert Shares How to Avoid Common Pitfalls in Preclinical Development

Behind every drug that reaches patients is a preclinical programme that most people never see Getting it right can be the difference between a molecule that moves smoothly into the clinic and one that stalls before it gets there Preclinical development brings together pharmacology toxicology formula...

BioAgilytix Expands Global Bioanalytical Capabilities with New Sydney Laboratory

BioAgilytix a global leader in bioanalytical services announces the opening of a new laboratory in North Ryde Sydney through biolabs its Australian laboratory business The expansion extends BioAgilytixs bioanalytical footprint across Australia Europe and the United States

EventsRead more...

14 - 15

Oct 2026

PDA Aseptic Manufacturing Excellence Conference

Pullman East Melbourne, Austra...

21 - 23

Oct 2026

21 - 22

Oct 2026

22 - 23

Oct 2026

PDA Aseptic Symposium 2026

Congress Square Nakanoshima, O...

26 - 28

Oct 2026

ACHEMA Middle East 2026

RICEC, Riyadh, KSA, Saudi Arab...

26 - 28

Oct 2026

World Orphan Drug Congress

RAI, Amsterdam, Netherlands

27 - 28

Oct 2026

PM& AC 2026

Novotel Hyderabad Convention C...

28 - 30

Oct 2026

LATEST NEWSRead more...

Zealand Pharma Enters into Collaboration with Generate Biomedicines on AI-Designed Protein Therapies for Metabolic Diseases

Zealand Pharma and Generate Biomedicines have entered into a multitarget collaboration and licensing agreement to develop proteinbased treatments for obesity and other metabolic diseases using artificial intelligence AI The collaboration will combine Zealand Pharmas expertise in metabolic diseases w...

Enodia Therapeutics Enters into Collaboration with Pfizer to Develop Small-Molecule Sec61 Inhibitors

Enodia Therapeutics has entered into a research collaboration and licensing agreement with Pfizer to discover and develop smallmolecule inhibitors targeting Sec a protein complex involved in the movement of newly formed proteins across cell membranes

InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China

InnoCare Pharma a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases announced today that the Center for Drug Evaluation CDE of Chinas National Medical Products Administration NMPA has approved its Investigational New Drug IND application for ICPB a bispeci...

Mint Pharmaceuticals and Bayer Expand Medicine Distribution in Canada

Mint Pharmaceuticals and Bayer have expanded their distribution partnership in Canada to include several additional medicines across womens health cardiovascular care and anticoagulation

Halozyme Expands argenx Collaboration to Include Two Additional Development Targets

Halozyme Therapeutics has expanded its global collaboration and licence agreement with argenx to develop and commercialise subcutaneous formulations for two additional exclusive targets using its ENHANZE drug delivery technology

CSL and Alentis Partner to Advance Lixudebart for Rare Kidney and Liver Diseases

CSL and Alentis Therapeutics have entered into a global collaboration to jointly develop and commercialise lixudebart an investigational treatment that targets claudin and could have applications across several kidney liver and other diseases